Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
PYXS is expected to report earnings to fall 11.49% to -30 cents per share on March 25
Q4'25
Est.
$-0.31
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.02
Q4'24
Missed
by $1.00
The last earnings report on November 03 showed earnings per share of -34 cents, missing the estimate of -34 cents. With 595.80K shares outstanding, the current market capitalization sits at 278.94M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PYXS showed earnings on November 03, 2025. You can read more about the earnings report here.